Down More Than 20% From Its High, Is Now the Time to Buy Eli Lilly Stock?

Eli Lilly (NYSE: LLY) is the most valuable healthcare stock in the world, with a market capitalization of nearly $700 billion. But in recent weeks, its share price has been falling. And now the stock is down over 20% from its 52-week high of $972.53. Could this be a great time to add the high-powered healthcare stock to your portfolio?Eli Lilly has been a fantastic growth stock to own in recent years. Entering trading this week, its five-year returns have totaled more than 550%. And that means a high valuation may have a lot to do with hesitancy from investors as there may be a lot of concern that the stock has become too expensive -- shares of Eli Lilly are trading at a price-to-earnings (P/E) multiple of more than 80.Even with the stock's recent drop in value, it is trading at an elevated valuation compared with what it has averaged in recent years.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool